The p53-regulated growth arrest and DNA damageinducible gene product Gadd45a has been recently identified as a key factor protecting the epidermis against ultraviolet radiation (UVR)-induced skin tumors by activating p53 via the stress mitogen-activated protein kinase (MAPK) signaling pathway. Herein we identify Gadd45a as an important negative regulator of two oncogenes commonly over-expressed in epithelial tumors: the p53 homologue DNp63a and b-catenin. DNp63a is one of the several p63 isoforms and is the predominant species expressed in basal epidermal keratinocytes. DNp63a lacks the N-terminal transactivation domain and behaves as a dominant-negative factor blocking expression of several p53-effector genes. DNp63a also associates with and blocks activation of the adenomatous polyposis coli (APC) destruction complex that targets free cytoplasmic bcatenin for degradation. While most b-catenin protein is localized to the cell membrane and is involved in cell-cell adhesion, accumulation of free cytoplasmic b-catenin will translocate into the nucleus where it functions in a bipartite transcription factor complex, whose targets include invasion and metastasis promoting endopeptidases, matrix metalloproteinases (MMP). We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3b (GSK3b) but also promotes GSK3b dephosphorylation at Ser9, which is essential for GSK3b activation, and resultant activation of the APC destruction complex. We demonstrate that lack of Gadd45a not only prevents DNp63a suppression and GSK3b dephosphorylation but also prevents free cytoplasmic b-catenin degradation after UV irradiation. The inability of Gadd45a-null keratinocytes to suppress b-catenin may contribute to the resulting observation of increased MMP expression and activity along with significantly faster keratinocyte migration in Matrigel in vitro and accelerated wound closure in vivo. Furthermore, epidermal keratinocytes treated with p38 MAPK inhibitors, both in vivo and in vitro, behave very similarly to Gadd45a-null keratinocytes after UVR. Similarly, Trp53-null mice are unable to attenuate DNp63a expression in epidermal keratinocytes after such stress. These findings demonstrate a dependence on Gadd45a-mediated p38 MAPK and p53 activation for proper modulation of DNp63a, GSK3b, and b-catenin after irradiation. Taken together, our results indicate that Gadd45a is able to repress DNp63a, b-catenin, and consequently MMP expression by two means: by maintaining UVR-induced p38 MAPK and p53 activation and also by associating with the APC complex. This implicates Gadd45a in the negative regulation of cell migration, and invasion.
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Introduction
The incidence of skin cancer has been increasing at an alarming rate and is the leading form of malignancy in the US. The skin is constantly challenged by ultraviolet radiation (UVR), and UVB (290-320 nm) is known to be the primary carcinogen responsible for most sporadic forms of basal and squamous cell carcinomas (Miller and Weinstock, 1994; Quinn, 1997) . While the guardian of the genome, p53, is essential to avert UVR-induced damage, we recently identified the p53-effector growth arrest and DNA damage-inducible gene product Gadd45a as a key regulator of p53 activity after UVR. p53 and its numerous downstream target genes are crucial for maintaining genomic integrity by regulating cellular processes such as DNA repair, cell cycle checkpoints, and apoptosis (Vousden and Lu, 2002) . Deregulation in any one (or combination) of these events may contribute to tumorigenesis. The absence of Gadd45a leads to loss of sustained p53 activation after UVR due to disruption of a pivotal stress-activated signal transduction pathway -the mitogen-activated protein kinase (MAPK) pathway. Under normal conditions, MAPKs signal developmental events involving cellular proliferation, differentiation, and death, but genotoxic stress will also trigger activation of this pathway (Robinson and Cobb, 1997; Martin-Blanco, 2000) . p53 is normally targeted for phosphorylation by p38 MAPK after UVR, which leads to its stabilization and activation (Bulavin et al., 1999) . In skin, Gadd45a is responsible for maintaining MAPK activation after UVR via a positive feedback loop and ultimately promotes either cell cycle arrest and/or apoptosis (Hildesheim et al., 2002) . Like Trp53-null mice, Gadd45a-null mice fail to mount a normal sunburn response to eliminate damaged cells (Ziegler et al., 1994) . Therefore, both Gadd45a-null and Trp53-null mice are prone to developing skin tumors after chronic UVR (Ziegler et al., 1994; Li et al., 1996; Hildesheim et al., 2002) . Consequently, Gadd45a is necessary for adequate p53 activation and ultimately for adequate genomic surveillance and tumor suppression.
In contrast to Gadd45a and p53, one of the p63 isoforms, DNp63a, has recently been identified as a dominant-negative factor that blocks p53 apoptotic effects in transgenic mice after UVR (Liefer et al., 2000) . The alternatively spliced p63 and p73 isoforms belong to the p53 family, and DNp63a, which lacks the N-terminal transactivation domain, is the predominant p63 species in the epidermis. Its expression is normally restricted to the proliferative basal and immediate suprabasal keratinocytes (Yang et al., 1998; Mills et al., 1999; Yang et al., 1999) . Both DNp63a mRNA and protein levels are known to drop after UVR, leaving p53 unchallenged (Liefer et al., 2000) . The significance of the Trp63 gene in the development and maintenance of the epidermis is highlighted by the fact that Trp63-null pups die of dehydration shortly after birth due to lack of a stratified epidermis. Additionally, Trp63-null mice lack other epithelial derivatives such as hair follicles, teeth and lacrimal, mammary and salivary glands (Mills et al., 1999; Yang et al., 1999) . It has been proposed that DNp63a may be necessary to counteract the effects of p53 in the basal layer of the epidermis in order to maintain both stem cell and proliferating/transient amplifying cell populations (Pellegrini et al., 2001) . In line with this concept, independent groups have reported the oncogenic properties of dominant-negative DNp63 isoforms that are frequently amplified and overexpressed in numerous types of epithelial tumors, such as lung and head and neck squamous cell carcinomas, nasopharyngeal carcinoma, and bladder carcinomas (Parsa et al., 1999; Park et al., 2000; Yamaguchi et al., 2000; Hu et al., 2002; Pelosi et al., 2002; Urist et al., 2002) .
The oncogenic properties of DNp63 isoforms have been strengthened further by its ability to regulate bcatenin stability and signaling (Patturajan et al., 2002) . b-catenin is known to play a critical role in not only cellcell adhesion but also in transcriptional regulation of key proliferation (cyclin D1 and c-Myc) and cell migration markers (matrix metalloproteinases -MMPs) (Brabletz et al., 1999; Crawford et al., 1999; Morin, 1999; Shtutman et al., 1999; Tetsu and McCormick, 1999; Behrens, 2000; Takahashi et al., 2002) . While the vast majority of b-catenin is associated with cell-cell adhesion complexes, a small fraction is present in a free cytoplasmic form, which is strictly regulated by phosphorylation and subsequent proteasome degradation. Wnt signaling through its receptor Frizzled (Frz) will result in blocked activation of the major regulator of bcatenin stability, namely glycogen synthase kinase 3b (GSK3b). Cytoplasmic accumulation of hypophosphorylated b-catenin will ultimately lead to it being translocated into the nucleus where it behaves as a bipartite transcription factor complex with T-cell factor/ lymphocyte enhancer binding factor (Tcf/Lef) (Peifer and Polakis, 2000) . It is well established that accumulation of b-catenin due to mutations and/or deregulated Wnt signaling will contribute to tumorigenesis and invasion/metastasis in numerous tissues, including skin tumors such as basal and squamous cell carcinomas, pilomatricomas, keratoacanthomas, and melanomas. (Morin, 1999; Peifer and Polakis, 2000; Polakis, 2000; Moon et al., 2002; van et al., 2003) . On the other hand, in the absence of Wnt signaling, b-catenin is phosphorylated at the N-terminus and subjected to ubiquitinmediated degradation by associating with a complex composed of adenomatous polyposis coli (APC), protein phosphatase 2A (PP2A), GSK3b, and Axin (Ikeda et al., 1998) . It is now evident that DNp63a promotes the accumulation of cytoplasmic b-catenin by inhibiting PP2A, which in turn is unable to dephosphorylate and activate its target GSK3b. This is accomplished by DNp63 forming an inactivating complex with both PP2A and GSK3b (Patturajan et al., 2002) .
Here, we identify the stress inducible p38 MAPK signaling pathway as a negative regulator of the oncogenes DNp63a and b-catenin. We provide evidence that Gadd45a is essential for negative regulation of bcatenin after genotoxic stress by not only blocking DNp63a expression via MAPK signaling but also through association with the same complex known to be modulated by both Wnt and DNp63. Our data also indicate that Gadd45a is important for GSK3b activation -a key requirement for b-catenin regulation. Moreover, the biological significance of Gadd45a in modulating b-catenin is demonstrated by the fact that Gadd45a-null mouse keratinocytes are not only able to migrate significantly faster in vitro but also undergo significantly faster wound closer in vivo. We therefore propose that, unlike DNp63a, Gadd45a association with the APC complex enables GSK3b to maintain an active status and consequently protect the epidermis against cancer by preventing the dangerous accumulation of free cytoplasmic/nuclear b-catenin. Taken together, our results indicate that Gadd45a-mediated p38 MAPK activation and APC complex association may antagonize Wnt signaling and negatively regulate b-catenin.
Results

UVB-induced downregulation of DNp63a in vivo is dependent on Gadd45a
Since caspase-1-mediated DNp63a protein degradation is known to be p53-dependent (Ratovitski et al., 2001) and since sustained UVR-induced p53 activity is dependent on a Gadd45a-mediated p38 MAPK activation feedback loop (Hildesheim et al., 2002) , we were interested in determining whether Gadd45a plays a role in regulating DNp63a protein levels in epidermal keratinocytes after UVR. Interestingly, unlike wild-type (wt) mice, Gadd45a-null mice are unresponsive to UVRinduced DNp63a suppression (Figure 1 ). Both newborn ( Figure 1a ) and adult ( Figure 1b ) Gadd45a-null mice retain nuclear staining for DNp63a of basal and immediate suprabasal epidermal keratinocytes at the previously established optimal time point of 24 h postirradiation (Liefer et al., 2000) . Moreover, Trp53-null mice responded similarly to Gadd45a-null mice ( Figure 1b ) and also retained DNp63a expression after UVR. Based on our previous findings (Hildesheim et al., 2002) , this suggests that DNp63a protein levels are regulated by the Gadd45a-dependent MAPK signaling pathway that activates p53. Wt mice, on the other hand, demonstrate normal reduction of DNp63a protein levels in response to the same insult. The in vivo effects of UVR on DNp63a parallels the results obtained in vitro with cultured mouse primary keratinocytes at both the mRNA ( Figure 2a ) and protein levels ( Figure 2b ). Consistent with the effects on intact skin, cultured Gadd45a-null primary keratinocytes are refractory to UVR at 24 h, although a transient effect is detected at 12 h. This is in sharp contrast to wt primary keratinocytes that demonstrate a dramatic reduction of DNp63a protein levels at both 12 and 24 h post-UVR. Therefore, as is the case for sustained MAPK activity (Hildesheim et al., 2002) , Gadd45a is required for sustained repression of DNp63a.
Figure 1 UVR-induced DNp63a repression in vivo. Immunostaining was performed on full thickness skin harvested from either newborn pups (a), or adult mice (b). (a) DNp63a expression patterns and levels in control and irradiated newborn skins. Nuclear DNp63a protein is normally modulated by UVR in both interfollicular (vertical arrows) and follicular keratinocytes (horizontal arrows). (b) compares DNp63a expression in wt, Gadd45a-null, and Trp53-null mice before and after UVR. Unlike newborns, in adult mice, DNp63a modulation is normally only present in interfollicular keratinocytes and not in deep follicular keratinocytes that are protected from UVR penetration. Abbreviations: Ctrl, control; UVR, UVB irradiation (24 h time point, 1500 Jm À2 ); WT, wild type Figure 2 In vitro correlation between DNp63a expression after UVR and its downstream targets. Either total RNA (a) or total protein lysates (b, c) were obtained from primary mouse keratinocytes derived from either wt or Gadd45a-null newborn mice. Cultured cells were irradiated with 250 Jm À2 of UVB; harvested at 12 and 24 h post-irradiation; and compared to control unirradiated cells. (a) corresponds to real-time PCR results on DNp63 expression. (b) corresponds to immunoblots comparing DNp63a expression levels to GSK3b dephosphorylation status of Ser9, and degradation of phosphorylated free cytoplasmic bcatenin. While the vast majority of b-catenin is stable and localized to the membrane, the relatively smaller fraction of free cytoplasmic b-catenin may be subject to phosphorylation and proteasome degradation. Total GSK3b and b-catenin were used as loading controls. Immunoblots in (c) compare wt keratinocytes treated with the proteasome inhibitor ALLN (10 mM) with untreated control cells before and 12 h after UVR. Total b-catenin was used as loading control. Abbreviations: C, control; þ / þ , wt; À/À, Gadd45a-null; P-GSK3b, phosphorylated GSK3b; GSK3b, total GSK3b; P-b-Cat, phosphorylated b-catenin; b-Cat, total b-catenin Gadd45a regulates DNp63a, b-catenin, and MMP J Hildesheim et al
UVB-induced GSK3b dephosphorylation and b-catenin degradation are dependent on Gadd45a
Since DNp63a is known to block PP2A activation of GSK3b by forming an inactivated complex with both the B56a catalytic subunit of PP2A and with GSK3b (Patturajan et al., 2002) , we were interested in determining whether GSK3b activation after UVR correlated with Gadd45a-mediated DNp63a suppression. Immunoblot analysis of mouse primary keratinocytes (Figure 2b ) demonstrate that DNp63a protein levels inversely correlate with dephosphorylation of GSK3b at Ser9, which is necessary for its activation. While wt cells are able to suppress DNp63a and dephosphorylate GSK3b at both 12 and 24 h post-UVB irradiation, Gadd45a-null cells are unable to sustain DNp63a repression and retained GSK3b in its inactive hyperphosphorylated state. Consequently, the results indicate that lack of Gadd45a prevented DNp63a suppression, which in turn blocked free cytoplasmic b-catenin from being targeted for GSK3b-dependent phosphorylation and subsequent proteasome degradation (Figure 2b ). These phenotypic effects observed in Gadd45a-null keratinocytes are readily reversed by over-expressing Gadd45a in these cells (data not shown). The importance of Gadd45a-dependent GSK3b dephosphorylation (and presumed activation) is emphasized by the fact that only wt keratinocytes are able to effectively eliminate b-catenin phosphorylated on Ser45. Normally, degradation of phosphorylated b-catenin requires the sequential phosphorylation of multiple sites. First, Ser45 is phosphorylated by casein kinase (CK) Ia (Liu et al., 2002) and CKIe (Sakanaka, 2002) , and is immediately followed by phosphorylation of Ser33, Ser37, and Thr41 by GSK3b. This in turn triggers rapid ubiquitination and proteasome degradation of b-catenin (van et al., 2003) . The effect on b-catenin degradation by UVR-induced GSK3b dephosphorylation is readily blocked by treating wt keratinocytes with the proteasome inhibitor ALLN (Figure 2c ). In conclusion, these results suggest that Gadd45a is necessary for DNp63a suppression and proper activation of the free cytoplasmic b-catenin degradation process. Since stress MAPK signaling is activated after UVR, and Gadd45a is needed for proper UVR-induced p38 MAPK activation (Hildesheim et al., 2002) , we investigated the importance of p38 MAPK in DNp63a and b-catenin down-regulation.
In vivo DNp63a and b-catenin suppression is mediated through Gadd45a-dependent p38 MAPK activation
In order to demonstrate that UVR-induced DNp63a suppression is mediated via Gadd45a-dependent p38 MAPK activation, the Gadd45a-null phenotype was mimicked by performing in vivo p38 MAPK inhibitor studies with adult wt mice (Figure 3a) . Wt mice treated with p38 inhibitor behave similarly to Gadd45a-null mice after UVR and are not able to effectively suppress DNp63a. Immunoblot analysis of cultured wt keratinocytes demonstrates that relative to controls, the p38 inhibitor delays UVR-induced suppression of DNp63a (Figure 3b) . Consistent with the effects on DNp63a, an appreciable delay in GSK3b dephosphorylation and bcatenin degradation is also noted. The effects of p38 inhibitor, both in vivo and in vitro, directly implicate the MAPK stress signaling pathway as a negative regulator of DNp63a, and consequently as a negative regulator of GSK3b and its substrate b-catenin.
Since MAPK signaling and modulation of downstream substrates may occur, in part, independently of protein synthesis, additional UVR experiments were conducted with the translation-blocking agent cyclohexamide (CHX) to test the degree to which post-translational effects of stress MAPK signaling Figure 3 Effects of the p38 MAPK inhibitor SB202190 on irradiated keratinocytes both in vivo and in vitro. (a) corresponds to immunohistochemistry with anti-p63 on wt adult mouse whole skin before and 24 h after UVR (1500 Jm À2 UVB). (b) compares by immunoblot untreated cultured wt mouse primary keratinocytes with irradiated keratinocytes (250 Jm À2 UVB), either treated or not treated with the p38 inhibitor (SB202190, 8 mg/kg). (c) immunoblots of wt keratinocytes 24 h after being treated with CHX (25 mg/ ml) and exposed to UVR. P-b-catenin levels remained elevated in irradiated cells treated with ALLN (10 mM) as a control (data not shown). Total b-catenin was used as a loading control. Abbreviations: Ctrl and C, control; UVR, UVB irradiation; þ Inhib, SB202190 treatment; ÀInhib, no SB202190 treatment; P-GSK3b, phosphorylated GSK3b; P-b-Cat, phosphorylated b-catenin; CHX, cyclohexamide Gadd45a regulates DNp63a, b-catenin, and MMP J Hildesheim et al contributes to DNp63a regulation. Interestingly, irradiated cells treated with CHX achieve partial suppression of DNp63a and b-catenin protein levels (Figure 3c ). The observed protein levels in irradiated cells treated with CHX are intermediate relative to irradiated cells not treated with CHX. This suggests that MAPK signaling modulates DNp63a and b-catenin protein stability via both translation-dependent and -independent pathways. These results not only further demonstrate the importance of translation-independent p38 MAPK signaling in DNp63a and b-catenin protein regulation, but also the importance of de novo protein synthesis, such as of Gadd45a, for complete degradation of these products. Since activation of the MAPK signaling pathway is necessary, but not sufficient, for complete b-catenin degradation without de novo protein synthesis, we investigated the possibility of b-catenin degradation being modulated in part by the ability of Gadd45a protein, like DNp63a (Patturajan et al., 2002) , to directly associate with components of the APC complex.
Gadd45a associates with APC complex proteins and substrate and promotes GSK3b dephosphorylation in vitro
While our data indicate that Gadd45a may partly regulate b-catenin through MAPK signaling, we also investigated the possibility that Gadd45a may contribute to b-catenin regulation by directly associating with APC complex proteins. Immune precipitation assays conducted with glutathione S-transferase (GST)-tagged Gadd45a protein and lysates from cultured primary keratinocytes demonstrate that Gadd45a is able to associate with multiple components of the APC complex, namely GSK3b and PP2A (Figure 4a ). Moreover, Gadd45a is also found to associate with b-catenin, which is a substrate of GSK3b (Ikeda et al., 1998; Crawford et al., 1999) . Interestingly, the association of Gadd45a with either the APC complex proteins or substrates occurs in an UVR-independent manner (data not shown). Furthermore, in order to demonstrate that Gadd45a is able to directly interact with some of the individual components of the APC complex, purified PP2A and GSK3b were also utilized in immunoprecipitations with GST-Gadd45a (Figure 4b ). Immunoblotting with antibodies against PP2A and GSK3b show a direct protein interaction with Gadd45a. This interaction was not observed with 14-3-3s that was used as a negative control for nonspecific binding associated with Gadd45a's highly acidic properties. In addition to its ability to interact with APC complex proteins, Gadd45a also contributes to GSK3b dephosphorylation in vitro. As shown in Figure 4c , exogenous Gadd45a will induce dephosphorylation, in a concentration-dependent manner, of endogenous GSK3b in Gadd45a-null total cell lysates. While GSK3b remains hyperphosphorylated in the absence of Gadd45a, GSK3b is readily dephosphorylated in the presence of increasing amounts of Gadd45a. Lastly, while Gadd45a contributes to dephosphorylation of GSK3b, Gadd45a is not a phosphatase and, unlike purified PP2A, purified Gadd45a is incapable of directly dephosphorylating purified GSK3b (data not shown).
Gadd45a-null keratinocytes have increased MMP expression and enhanced keratinocyte migration in vitro and faster wound closure in vivo
Since b-catenin contributes to transcriptional regulation of MMPs (Brabletz et al., 1999) and our data show that Gadd45a interacts with and regulates b-catenin, we were interested in determining whether loss of Gadd45a results in altered MMP expression and/or activity. A combination of Northern blots (Figure 5a ), immunoblots (Figure 5b) , and MMP activity assays by zymography (Figure 5c ) revealed that Gadd45a-null keratinocytes not only express higher levels of MMP-7 and MMP-9 but also display higher activity for both MMP-3 and MMP-9 (Figure 5c ). This demonstrates that Gadd45a may be required to suppress bcatenin-mediated MMP expression.
Since elevated MMP levels are frequently detected in tumor tissues and promote tumor growth, invasion, and metastasis (Powell et al., 1993; Yamamoto et al., 1995; Vihinen and Kahari, 2002) , we set out to demonstrate that the MMP expression and activity differences observed in cultured primary keratinocytes have biological significance both in vitro and in vivo. Primary keratinocytes derived from both Gadd45a-null and wt mice were subject to an in vitro invasion assay by seeding equal numbers of cells onto Matrigel and scored for transmigration 24 h after being seeded (Figure 5d ). Gadd45a-null keratinocytes invaded the gel at a modest yet significantly higher rate than wt keratinocytes (1.7-fold, P ¼ 0.005). Moreover, wound-healing experiments conducted in vivo support the in vitro data above. The 3-mm full-thickness punch wounds healed appreciably faster (Po0.03 days 1-5; P ¼ 0.06 day 6) over a 6-day interval in Gadd45a-null mice relative to wt mice Gadd45a regulates DNp63a, b-catenin, and MMP J Hildesheim et al (Figure 5e ). In summary, the absence of Gadd45a leads to increased MMP expression in epidermal keratinocytes, which may contribute to increased migration potential.
Discussion
In this report, we have identified Gadd45a as a required factor for the suppression of b-catenin signaling via the stress-activated p38 MAPK pathway. Herein we establish that Gadd45a acts as a negative regulator of bcatenin at two inter-related levels ( Figure 6 ): initially Gadd45a contributes to b-catenin degradation by maintaining p38 activation via a positive feedback loop. Stress-activated p38 MAPK will phosphorylate and activate p53 (Bulavin et al., 1999) , and p53 in turn has been documented to bind to and target DNp63a for degradation via a caspase-1-dependent pathway Figure 6 Role of Gadd45a in b-catenin regulation. Gadd45a-dependent regulation of b-catenin may occur on two levels. First, translation-independent suppression of b-catenin through stress MAPK signaling is achieved via a positive feedback loop by basal levels of Gadd45a protein maintaining MTK1 and p38 MAPK activity after UVR. Activated p38 MAPK will target p53 for phosphorylation, and consequently increase p53's stability and activity (designated by *). p53 will in turn bind to and direct DNp63a for caspase-1-mediated degradation. The absence of DNp63a protein enables APC to form an active complex with PP2A and GSK3b. As part of the APC complex, reactivated GSK3b will then phosphorylate and target b-catenin for ubiquitination and immediate proteasome degradation. In addition to DNp63a, Wnt/Frz signaling also opposes GSK3b activation. Second, translation-dependent suppression of b-catenin is achieved by accumulation of newly synthesized Gadd45a (as a downstream target of active p53). Gadd45a protein will directly interact with the APC complex and contribute to its activation (designated by #). Keratinocytes lacking Gadd45a are unable to adequately dephosphorylate and activate GSK3b and also retain high levels of DNp63a, which disrupts APC complex formation and activation. This ultimately results in cytoplasmic accumulation of hypophosphorylated and stable b-catenin, which readily translocates into the nucleus and promotes the expression of numerous target genes including MMP genes, cyclin D1, and c-Myc. Deregulation of these critical factors will contribute to key events in tumorigenesis such as tumor invasion, metastasis, and cell cycle deregulation In vivo wound healing assay of 3 mm punches over a 6-day period (day 1, P ¼ 0.002; day 2, P ¼ 0.008; day 3, P ¼ 0.03; day 4, P ¼ 0.03; day 5, P ¼ 0.006; day 6, P ¼ 0.06). þ / þ (), wt; À/À (J), Gadd45a-null Gadd45a regulates DNp63a, b-catenin, and MMP J Hildesheim et al (Ratovitski et al., 2001) . Moreover, DNp63a has recently been shown to promote cytoplasmic accumulation of b-catenin by associating with both GSK3b and PP2A and blocking the latter from dephosphorylating and activating GSK3b (Patturajan et al., 2002) . Since DNp63a down-regulation after UVR is Gadd45a-dependent, we conclude that Gadd45a, in part, achieves b-catenin suppression by repressing DNp63a through p38 MAPK and p53 activation. Secondly, activation of the stress MAPK signaling pathway will result in increased accumulation of Gadd45a protein (Hildesheim et al., 2002) . Since Gadd45a is a Trp53-effector gene (Amundson et al., 1998) , accumulation of newly synthesized Gadd45a protein enables the second arm of b-catenin regulation by Gadd45a to take effect ( Figure 6 ). We demonstrate in Figure 3c that effective suppression of both DNp63a and b-catenin is dependent not only on translation-independent MAPK activation but also on translation-dependent events. This likely involves direct association of accumulated Gadd45a with several APC complex proteins that promote dephosphorylation of SK3b. Interestingly, even though Gadd45a directly interacts with GSK3b, purified Gadd45a is unable to dephosphorylate purified GSK3b (data not shown). In addition, Gadd45a failed to increase PP2A activity in vitro, which indicates that Gadd45a does not directly activate PP2A (data not shown). This suggests that suppression of b-catenin is likely achieved by Gadd45a acting as an adaptor that facilitates an effective interaction between GSK3b and PP2A. Interestingly, two GSK3b substrates that co-precipitate with Gadd45a, b-catenin and cyclin D1, are blocked from degradation after UVR in Gadd45a-null keratinocytes (cyclin D1 data not shown). Studies elucidating this potential function for Gadd45a as an adaptor protein remains to be determined but are consistent with loss of normal regulation of b-catenin after UVR.
The biological significance of the effects of Gadd45a on DNp63a and b-catenin regulation is evident in the MMP expression differences and resulting cell migration and wound healing differences observed between wt and Gadd45a-null keratinocytes. MMPs are zinc-dependent endopeptidases that normally play an important role in remodeling of extracellular matrix during developmental, angiogenesis, and tissue repair events (Brinckerhoff and Matrisian, 2002; Vihinen and Kahari, 2002) . Conversely, deregulated MMP expression result in numerous pathologic conditions associated with excessive connective tissue breakdown, such as rheumatoid arthritis, chronic ulcers, dermal photoaging, and more importantly tumor cell invasion and metastasis (McCawley and Matrisian, 2000; Vihinen and Kahari, 2002) . Both squamous and basal cell carcinomas are characterized by overexpression of numerous MMPs, including MMP-3, -7, and -9 among others (Muller et al., 1991; Pyke et al., 1992; Karelina et al., 1994; Kusukawa et al., 1996; Tsukifuji et al., 1999) . Interestingly, deregulated DNp63a expression is also detected in squamous cell carcinomas and other epithelial tumors (Parsa et al., 1999; Hibi et al., 2000; Yamaguchi et al., 2000; Hu et al., 2002; Pelosi et al., 2002) . Additionally, the connection between deregulated b-catenin signaling and cancer is also well documented. In fact, along with the commonly described mutations in either APC and/ or b-catenin associated with cancers of the colon, prostate, ovaries, brain, liver, and others (Morin, 1999) , deregulated Wnt-1 expression has been described in head and neck basal cell carcinomas (Leethanakul et al., 2000) . The regulatory link between Gadd45a and b-catenin is reflected in the fact that we detect dramatic increases in both expression and activity of key MMPs in epidermal keratinocytes. While direct b-catenin transcriptional regulation of MMP-3 and -9 has not been established, MMP-7 has been identified as one of the many genes targeted by b-catenin (Brabletz et al., 1999; Crawford et al., 1999) . Biochemically, enzymatic activity for both MMP-7 and -9 can be magnified due to the cooperative nature of this family of enzymes. MMP-3 protein, for instance, will target MMP-7 and -9, among others, for cleavage and activation, and MMP-7 will target MMP-9 in the same manner (Vihinen and Kahari, 2002) . Therefore, a small increase in protein expression could render broad and significant changes in enzymatic activity.
While Gadd45a, through p38 MAPK activation, may normally counter the effects of Wnt-1 on cytoplasmic accumulation of b-catenin, mutations or loss of Gadd45a may compromise the ability to suppress b-catenin and ultimately lead to grave consequences. We previously reported that Gadd45a-null mice are at significantly increased risk for developing UVR-induced tumors (Hildesheim et al., 2002) . This fact, along with the results presented in this report, provide a direct link between Gadd45a, DNp63a, GSK3b, b-catenin, and MMPs and indicate a potential role for Gadd45a in suppressing tumor progression. The association between Gadd45a mutations and human cancer has already been reported in pancreatic cancer (Yamasawa et al., 2002) . The relative importance of the p38 MAPK signaling pathway in tumor suppression is becoming apparent, and restoring normal p38 MAPK signaling may retard or even prevent the invasive and metastatic potential of advanced tumors. In light of this, identifying MAPK modulators such as Gadd45a and better understanding their function is critical for the development of therapeutics that may target p38 MAPK regulation.
Materials and methods
Immunohistochemistry
Mouse trunk skin was formalin fixed and paraffin embedded 24 h post-UVR. Standard peroxidase-based immunohistochemistry with the ABC kit (Vectastain ABC kit, Vector Laboratories, Inc.) was performed with anti-p63 antibodies (1 : 500 dilution, 4A4 clone -Santa Cruz Biotech.).
Transmigration assay
Transwell inserts (Costar, MA, USA) were coated with Matrigel (Collaborative Biomedical, MA), and diluted 1 : 20 in PBS. A total of 50 000 keratinocytes were seeded and cultured for 24 h. Next, cells on the upper side of the coated membrane were removed by gentle scraping, and cells on the bottom side of the membrane were stained with crystal violet and rinsed in water. The membrane was placed in an extraction buffer (0.1% Triton X-100), which was then subject to spectrophotometric readings at 595 nm. Absorption readings were used to determine the migration rate differences between the genotypes.
Wound healing assay
Full-thickness cutaneous wounding was performed with a 3 mm biopsy punch. Each mouse had two 3 mm punches on their dorsal surface. Avertin (2.5%) was used as the anesthetic during surgery at a dose of 0.015-0.018cc/g body weight. Analgesics: Children's Tylenol R for pain was provided in the drinking water at a concentration of 300 mg/kg body weight. Antibiotics: SMZ-TMP (Sulfamethoxazole and Trimethoprim Oral Suspension, 2 ml/oz drinking water) was also provided to minimize infection of the wound. Wounds were measured daily with a caliper in a blinded manner for up to 6 days.
Cell culture
Primary mouse keratinocytes and dermal fibroblasts were derived from multiple litters as previously described (Hildesheim et al., 2002) , and cyclohexamide (25 mg/ml), SB202190 (10 mM), and ALLN (10 mM) treatment was initiated 30 min prior to UVR exposure.
Zymography
Casein and gelatin zymography were performed by first concentrating the cultured medium 15-fold with centricon Plus-20 centrifugation filters as specified by the manufacturer (Millipore PL-10). Concentrated medium was applied to a 10% SDS-polyacrylamide gel containing 1.5 mg/ml of zymogen (Sigma, MI, USA). Following electrophoresis, the gel was washed twice for 30 min in 2.5% Triton X-100 (Sigma, MI, USA) and subsequently incubated in substrate buffer (50 mM Tris-HCl, pH 7.6, 5 mM CaCl 2 ) at 371C for 24 h. The gel was stained with 0.2% coomassie brillient blue R-250.
Northern blot
In total, 15 mg of Trizol (Invitrogen)-extacted total RNA was subject to standard procedures utilizing either MMP-9 cDNA (I.M. A.G.E. 1480326) or GAPDH as templates to generate randomly primed 32 P-labeled probes.
Immunoblot
Total cell lysates extracted with standard RIPA buffer were subject to SDS-PAGE (Novex 10 or 12% gels, Invitrogen
Corp.) and blotted onto an Immobilon TM -P transfer membrane (Millipore Corp.). Cell Signaling Technology protocols were used for detection by chemiluminescense (Amersham Biosciences) with the following antibodies and dilutions: p63 (4A4, 1 : 200), 1 : 200) , and MMP-9 (M-17, 1 : 200) from Santa Cruz Biotechnology, Inc.; b-catenin (9562, 1 : 1000), P-b-catenin (9565 and 9561, 1 : 1000), GSK3b (9332, 1 : 1000), and P-GSK3b (9336, 1 : 1000) from Cell Signaling Technology; MMP-7 (1 : 5000, BioMol Research Laboratories, Inc.). Secondary antibodies: HRP-linked antimouse IgG (1 : 5000) and HRP-linked anti-rabbit IgG (1 : 5000) from Amersham Pharmacia Biotech.
UV irradiation assay
Either newborn C57BL6/129 pups or 6-week-old depilated adult C57BL6/129 mice were irradiated with 1000 or 1500 Jm À2 UVB, respectively. Details about the UVB source and irradiation protocols were previously described (Hildesheim et al., 2002) . SB202190 treatment of adult mice (6 weeks old, 8 mg/kg dose, Calbiochem) was initiated 30 min before UVR and repeated every 8 h for a 24-h period.
Immunoprecipitation assay
GST fusion proteins were expressed in Escherichia coli strain BL21(DE3)pLysS (Novagen) with 1 mM IPTG for 6 h, 301C. Bacterial lysates were prepared with BugBuster Reagent as recommended (Novagen); and protein purification was performed with GST Bind Resin (Novagen). Keratinocytes were lysed with 50 mM Tris HCl, pH 8.0, 150 mM NaCl, 0.2% NP-40, 20 mM b-glycerophosphate, and protease inhibitors. Cell lysates were pre-incubated with GST agarose beads for 1 h, followed by overnight incubation at 41C with 1 mg total protein from cell lysate and 15 mg of GST fusion proteins. Beads were then centrifuged and washed with 0.2% NP-40 lysis buffer. Bound proteins were eluted with 5 mM glutathione and 1 mg of protein was resolved by 12% SDS/PAGE.
Phosphatase assay
Gadd45a-null keratinocytes were lysed in buffer without bglycerophosphate (50 mM TrisHCl, pH 8.0, 150 mM NaCl, 0.2% NP-40, and protease inhibitors). A total of 100 mg of total cell lysate was incubated with increasing amounts of recombinant Gadd45a for 30 min at 301C in lysis buffer containing 1 mM MnCl 2 , 5 mM MgCl 2 , 1 mM EGTA, and 1 mM DTT. Proteins were resolved by SDS/PAGE (12%).
